Effect of atropine and vagotomy on response of transplanted pancreas.
It is well established that atropine and vagotomy inhibit pancreatic enzyme secretion in response to intestinal stimulants such as fat or amino acids. These effects are usually attributed to interference with hypothetical vagal cholinergic mechanisms that facilitate release of cholecystokinin. To determine whether atropine or vagotomy interferes with release of humoral stimulants of pancreatic enzyme secretion, we studied their effect on protein secretion from an autotransplanted portion of pancreas in response to intestinal stimulants in dogs. The transplanted pancreas was as sensitive as the intact pancreas to stimulation by exogenous caerulein, a cholecystokinin-like peptide, and this response was not altered by atropine or vagotomy. Therefore, if vagotomy or atropine interferes with release of humoral pancreatic stimulants, they would be expected to reduce the response of the transplanted pancreas just as they do of the intact pancreas. Truncal vagotomy caused no significant change in protein secretion from the transplant in response to intestinal perfusion with sodium oleate or tryptophan. Atropine was tested only against sodium oleate and caused no change in response. We conclude that release of humoral pancreatic excitants of protein secretion in response to intestinal stimulants is not significantly changed by atropine or vagotomy.
D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D002108:Ceruletide / Q000037:antagonists & inhibitors; D002766:Cholecystokinin / Q000378:metabolism*; D004285:Dogs; D005260:Female; D010179:Pancreas / Q000294:innervation / Q000378:metabolism*; D016035:Pancreas Transplantation; D014182:Transplantation, Autologous; D014630:Vagus Nerve / Q000502:physiology*
D001285:Atropine; D002108:Ceruletide; D002766:Cholecystokinin